USP: Third Instrument Qualification Stimuli published for Comments
As of early September 2022, the stimuli document "Analytical Instrument and System (AIS) Qualification: The Qualification Life Cycle Process" has been posted on the USP Pharmacopeial Forum website for comment. Remarks and comments on this draft may be submitted until November 30, 2022.
This draft is divided into the following chapters and subchapters:
- Introduction
- Life Cycle Process Descriptions
o User Requirement Specifications
o Vendor Contribution to the Qualification Process
o Design Qualification
o Purchase Order
o Installation Qualification
o Operational Qualification
o Performance Qualification
o Qualification Summary Report
o Operational Use and System Suitability Tests
o New Analytical Procedures
o Ongoing Performance Verification of the Qualified State - Conflict of Interest Disclaimer
- References
You can get to and comment the Stimuli document "Analytical Instrument and System (AIS) Qualification: The Qualification Life Cycle Process" after a one-time registration on the Pharmacopeial Forum website.
Here you can also view the previous Stimuli articles on "Analytical Instrument and System (AIS) Qualification, to support Analytical Procedure Validation over the Life Cycle- PF 48(1)" and "Measurement Uncertainty Evaluation Relevant to Analytical Instrument and System (AIS) Qualification - The Role of Measurement Uncertainty Concepts within the AIS - PF 48(2)", which were available for comments earlier this year.
Related GMP News
12.01.2026FDA Warning Letter: OOS Handling and HPLC Method Validation
12.01.2026Eurachem Publishes New Guide on the Fitness for Intended Use of Analytical Equipment and Systems
07.01.2026Revised Ph. Eur. Chapters 2.9.42 and 2.9.43 on Dissolution Testing
07.01.2026Korean MFDS Publishes Data Collection on Dissolution Test Methods
18.12.2025FDA Form 483: Excel-Based Data Falsification and Duplicate Log Books
18.12.2025Questions and Answers on System Suitability Tests (SST) - Part 1



